New breakthrough Alzheimer's drug gets unanimous backing from FDA advisors - New York Post
- New breakthrough Alzheimer's drug gets unanimous backing from FDA advisors New York Post
- FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval CNBC
- FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment Yahoo Finance
- Alzheimer's drug with modest benefits wins backing of FDA advisers Nature.com